BioHarvest Sciences Inc. (CSE: BHSC)
Canada
· Delayed Price · Currency is CAD 8.75
0.00 (0.00%)
Nov 19, 2024, 3:59 PM EST
BioHarvest Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Revenue | 19.13 | 12.67 | 5.5 | 2.1 | 0.4 | 0.22 | Upgrade
|
| Revenue Growth (YoY) | 115.57% | 130.48% | 161.56% | 430.81% | 81.65% | -51.45% | Upgrade
|
| Cost of Revenue | 9.29 | 7.04 | 4.28 | 1.43 | 0.26 | 0.19 | Upgrade
|
| Gross Profit | 9.84 | 5.63 | 1.22 | 0.67 | 0.14 | 0.03 | Upgrade
|
| Selling, General & Admin | 13.53 | 12.23 | 9.52 | 5.03 | 4.44 | 0.92 | Upgrade
|
| Research & Development | 4.07 | 3.37 | 2.31 | 4.13 | 1.26 | 1.35 | Upgrade
|
| Operating Expenses | 17.6 | 15.6 | 11.83 | 9.16 | 5.71 | 2.27 | Upgrade
|
| Operating Income | -7.76 | -9.97 | -10.61 | -8.49 | -5.57 | -2.24 | Upgrade
|
| Interest Expense | -4.76 | -0.94 | -0.51 | -0.81 | -0.5 | -2.24 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.03 | 0.03 | 0.23 | 0.29 | -0.08 | -0.24 | Upgrade
|
| Other Non Operating Income (Expenses) | -3.74 | -1.69 | -0.35 | -0.82 | 0.15 | -0.52 | Upgrade
|
| EBT Excluding Unusual Items | -16.23 | -12.56 | -11.24 | -9.83 | -5.99 | -5.24 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | - | -0.07 | Upgrade
|
| Other Unusual Items | - | - | - | - | -0.6 | - | Upgrade
|
| Pretax Income | -16.23 | -12.56 | -11.24 | -9.83 | -6.58 | -5.31 | Upgrade
|
| Earnings From Continuing Operations | -16.23 | -12.56 | -11.24 | -9.83 | -6.58 | -5.31 | Upgrade
|
| Net Income | -16.23 | -12.56 | -11.24 | -9.83 | -6.58 | -5.31 | Upgrade
|
| Net Income to Common | -16.23 | -12.56 | -11.24 | -9.83 | -6.58 | -5.31 | Upgrade
|
| Shares Outstanding (Basic) | 14 | 14 | 13 | 12 | 10 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 14 | 14 | 13 | 12 | 10 | 3 | Upgrade
|
| Shares Change (YoY) | 8.55% | 3.67% | 4.87% | 28.15% | 229.29% | 642.65% | Upgrade
|
| EPS (Basic) | -1.13 | -0.93 | -0.86 | -0.79 | -0.68 | -1.80 | Upgrade
|
| EPS (Diluted) | -1.13 | -0.93 | -0.86 | -0.79 | -0.68 | -1.80 | Upgrade
|
| Free Cash Flow | -9.19 | -10 | -10.5 | -8.43 | -4.05 | -2.42 | Upgrade
|
| Free Cash Flow Per Share | -0.64 | -0.74 | -0.80 | -0.68 | -0.42 | -0.82 | Upgrade
|
| Gross Margin | 51.44% | 44.45% | 22.17% | 31.87% | 34.85% | 13.30% | Upgrade
|
| Operating Margin | -40.54% | -78.65% | -193.02% | -403.95% | -1405.81% | -1027.52% | Upgrade
|
| Profit Margin | -84.84% | -99.15% | -204.37% | -467.51% | -1662.63% | -2435.78% | Upgrade
|
| Free Cash Flow Margin | -48.02% | -78.88% | -190.92% | -401.24% | -1022.22% | -1108.72% | Upgrade
|
| EBITDA | -7.21 | -9.58 | -10.33 | -8.43 | -5.52 | -2.18 | Upgrade
|
| EBITDA Margin | -37.71% | -75.57% | -187.83% | - | - | - | Upgrade
|
| D&A For EBITDA | 0.54 | 0.39 | 0.29 | 0.07 | 0.05 | 0.06 | Upgrade
|
| EBIT | -7.76 | -9.97 | -10.61 | -8.49 | -5.57 | -2.24 | Upgrade
|
| EBIT Margin | -40.54% | -78.65% | -193.02% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.